Angels Santé logo

Angels Santé

Europe, Ile-de-France, France, Puteaux

Description

Angels Santé is a prominent French business angel network, established in 2008, exclusively dedicated to fostering innovation within the health sector. Based in Puteaux, the network comprises over 100 experienced business angels, many of whom bring deep expertise from medical, scientific, and entrepreneurial backgrounds. This collective knowledge allows Angels Santé to provide not only capital but also strategic guidance and industry connections to its portfolio companies. The network primarily targets early-stage startups across a broad spectrum of health-related fields, including biotechnology, medical devices (medtech), digital health (e-health), and healthcare services.

The investment strategy of Angels Santé is characterized by its focus on high-potential, disruptive innovations. The network typically provides initial funding rounds, often participating in seed or pre-seed stages. While individual angels contribute varying amounts, the collective first cheque from the Angels Santé network into a single company generally ranges from €100,000 to €500,000, which translates to approximately $108,000 to $540,000 USD. Angels Santé frequently co-invests with other venture capital funds, corporate partners, and public institutions, leveraging its extensive network to facilitate larger funding rounds and provide robust support for its portfolio companies' growth.

Since its inception, Angels Santé has demonstrated a significant impact on the European health tech ecosystem, having invested in over 100 innovative companies. The cumulative funds raised by their portfolio companies are reported to exceed €1 billion, underscoring the network's role in scaling promising healthcare ventures. Beyond financial investment, Angels Santé emphasizes active mentorship and networking opportunities, connecting founders with seasoned professionals and potential partners. This comprehensive support system makes Angels Santé a key player for health startups seeking both capital and strategic guidance in France and beyond.

Investor Profile

Angels Santé has backed more than 31 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 10% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Angel rounds (top funding stages).
  • Majority of deals are located in France, United States, India.
  • Strong thematic focus on Health Care, Biotechnology, Medical Device.
  • Led 1 rounds in the past year.
  • Typical check size: $108K – $540K.

Stage Focus

  • Seed (68%)
  • Series Unknown (19%)
  • Angel (6%)
  • Pre Seed (3%)
  • Series A (3%)

Country Focus

  • France (94%)
  • United States (3%)
  • India (3%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Artificial Intelligence (Ai)
  • Mobile Apps
  • Collaboration
  • Software
  • Biopharma
  • Rehabilitation
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Angels Santé frequently co-invest with?

Femmes Business Angels
Europe, Ile-de-France, France, Paris
Co-Investments: 7
NF
Europe, Nord-Pas-de-Calais, France, Lille
Co-Investments: 3
Paris Business Angels
Europe, Ile-de-France, France, Paris
Co-Investments: 8
GO CAPITAL
Europe, Bretagne, France, Rennes
Co-Investments: 3
NW
Europe, Haute-Normandie, France, Rouen
Co-Investments: 2
LB
Europe, Ile-de-France, France, Paris
Co-Investments: 7
Wille Finance
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 8
IB
North America, New York, United States, New York
Co-Investments: 3
50 Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3

Which angels does Angels Santé often collaborate with?

DG
Europe, Ile-de-France, France, Paris
Shared Deals: 1

What are some of recent deals done by Angels Santé?

AUSTRAL Dx

Paris, Ile-de-France, France

AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs.

ManufacturingMedicalMedical Device
SeedJul 24, 2025
Amount Raised: $1,110,580
Ensweet

Loos, Nord-Pas-de-Calais, France

Ensweet is a telemedicine platform that develops telerehabilitation solutions.

Health CareMedicalMedical DeviceRehabilitationTelehealth
SeedMay 20, 2025
Amount Raised: $3,375,543
MB Therapeutics

Montpellier, Languedoc-Roussillon, France

MB Therapeutics is a pharmaceutical firm that provides patient-centric solutions for developing and producing tailored medicines.

3D PrintingMedicalPharmaceutical
SeedFeb 24, 2025
Amount Raised: $2,103,877
Sirius NeoSight

Lyon, Rhone-Alpes, France

Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.

BiopharmaBiotechnologyHealth Care
SeedFeb 4, 2025
Amount Raised: $4,563,605
HEPHAISTOS-Pharma

Orsay, Ile-de-France, France

Hephaistos Pharma is a biotech company developing oncology treatments.

BiotechnologyOncology
SeedJan 23, 2024
Amount Raised: $4,885,898
SeaBeLife

Roscoff, Bretagne, France

SeaBeLife is a biotechnology company that develops a range of drug candidates.

BiotechnologyMedical
SeedSep 26, 2023
Amount Raised: $1,268,298
Abcely

Nantes, Pays de la Loire, France

Abcely is a biotech firm that is working on a novel anti-cancer medication.

BiotechnologyHealth Care
SeedSep 21, 2023
Amount Raised: $2,558,494
Odimma

Illkirch-graffenstaden, Alsace, France

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

BiotechnologyHealth CareLife SciencePrecision MedicineTherapeutics
SeedApr 13, 2023
Amount Raised: $2,000,000
Ensweet

Loos, Nord-Pas-de-Calais, France

Ensweet is a telemedicine platform that develops telerehabilitation solutions.

Health CareMedicalMedical DeviceRehabilitationTelehealth
SeedFeb 23, 2023
Amount Raised: $2,543,569
Healshape

Villeurbanne, Rhone-Alpes, France

Healshape is a 3D bioprinting regenerative medecine company.

3D PrintingBiotechnology
SeedJun 28, 2022
Amount Raised: $6,314,699